Editorials

Reducing the transmission of genital herpes

BMJ 2005; 330 doi: http://dx.doi.org/10.1136/bmj.330.7484.157 (Published 20 January 2005) Cite this as: BMJ 2005;330:157
  1. Simon E Barton, clinical director (simon.barton@chelwest.nhs.uk)
  1. Dept of HIV/Genitourinary Medicine, Chelsea and Westminster Hospital, London SW10 9NH

    Antiviral therapy is effective but should be used with safer sex practices and counselling

    Seven years ago, an editorial published in this journal called for studies to clarify the role of antiviral treatment in preventing the transmission of genital herpes.1 In the intervening years, seroprevalence studies in the United States have shown that the rate of infection with herpes simplex virus type 2 (HSV-2) has risen to 22%,2 whereas in Europe, rates between 4% and 44% have been reported.3 Support for an association between HSV-2 and HIV acquisition and transmission has increased, and anxiety about infecting their sexual partner is still among the top three concerns of people with genital herpes.46 We know that antiviral treatment reduces symptomatic and asymptomatic shedding of HSV from genital mucosa,79 but until now we have not known whether this would translate into a real, clinically important reduction in the transmission of genital herpes to an uninfected partner.

    A recently published study was undertaken in 1484 heterosexual, immunocompetent couples to determine if daily valaciclovir could reduce the sexual transmission of genital herpes.10 One partner of each couple had clinically diagnosed genital HSV-2 infection, and the other …

    Sign in

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe